SmithKline buys research centre
SmithKline buys research centre
SmithKline Beecham, the pharmaceuticals giant, has paid $120m (about £75m) for the former Sterling Winthrop pharmaceutical research and development complex near Philadelphia. Sterling Winthrop had planned the site as its central research and development operation until it was acquired by the French Sanofi group. SmithKline will move 500 research staff to the plant to fulfil its US development needs.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies